Opko Health Inc. provides drive-through testing
Opko Health Inc.(OPK) currently trades at $1.43 and has grown by 3% in the past 24 hours. It is encouraging to note that given the widespread COVID-19 outbreak, OPKO’s BioReference Laboratories is currently accepting specimens for COVID-19 testing from healthcare providers, clinics and health systems throughout the United States.
Based on this information, investorsQ rates this stock a 5 out of 10. We give it this rating because Opko’s BioReference Laboratories will provide testing at drive-through locations for residents of the city by appointment. The high forecast for Opko Health Inc. is $6 and the low is $3. Notably, the company’s market cap is $957.85 with a 52 week high of $2.91 and a 52 week low of $1.33.